Fifth Third Bancorp
TNDM icon

Fifth Third Bancorp’s Tandem Diabetes Care TNDM Stock Holding History

Fifth Third Bancorp’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Sell
22,126
-479
-2% -$8.36K ﹤0.01% 2320
2026
Q1 		$433K Buy
22,605
+21,566
+2,076% +$469K ﹤0.01% 2113
2025
Q4 		$22.8K Buy
1,039
+145
+16% +$2.62K ﹤0.01% 1830
2025
Q3 		$10.9K Buy
894
+491
+122% +$6.65K ﹤0.01% 2117
2025
Q2 		$7.51K Sell
403
-28
-6% -$555 ﹤0.01% 2101
2025
Q1 		$8.26K Buy
431
+4
+0.9% +$117 ﹤0.01% 2079
2024
Q4 		$15.4K Sell
427
-10
-2% -$338 ﹤0.01% 1853
2024
Q3 		$18.5K Buy
437
+8
+2% +$339 ﹤0.01% 1799
2024
Q2 		$17.3K Buy
429
+29
+7% +$1.21K ﹤0.01% 1757
2024
Q1 		$14.2K Buy
400
+74
+23% +$1.98K ﹤0.01% 1767
2023
Q4 		$9.64K Buy
326
+92
+39% +$1.91K ﹤0.01% 1973
2023
Q3 		$4.86K Buy
234
+52
+29% +$1.43K ﹤0.01% 2183
2023
Q2 		$4.47K Sell
182
-351
-66% -$11.3K ﹤0.01% 2230
2023
Q1 		$21.6K Buy
533
+71
+15% +$2.94K ﹤0.01% 1797
2022
Q4 		$20.8K Buy
462
+70
+18% +$3.17K ﹤0.01% 1690
2022
Q3 		$19K Sell
392
-48
-11% -$2.63K ﹤0.01% 1714
2022
Q2 		$26K Buy
440
+344
+358% +$28.2K ﹤0.01% 1633
2022
Q1 		$11K Sell
96
-4,096
-98% -$478K ﹤0.01% 2036
2021
Q4 		$631K Buy
4,192
+4,136
+7,386% +$558K ﹤0.01% 670
2021
Q3 		$7K Buy
+56
New +$6.17K ﹤0.01% 2126
2020
Q2 		– Sell
-3,280
Closed -$211K – 2245
2020
Q1 		$211K Sell
3,280
-500
-13% -$35K ﹤0.01% 817
2019
Q4 		$225K Buy
3,780
+3,280
+656% +$202K ﹤0.01% 905
2019
Q3 		$29K Sell
500
-1,500
-75% -$95.7K ﹤0.01% 1530
2019
Q2 		$129K Sell
2,000
-1,520
-43% -$98.1K ﹤0.01% 1052
2019
Q1 		$224K Buy
3,520
+3,020
+604% +$159K ﹤0.01% 851
2018
Q4 		$19K Hold
500
– – ﹤0.01% 1615
2018
Q3 		$21K Hold
500
– – ﹤0.01% 1635
2018
Q2 		$11K Buy
+500
New +$6.15K ﹤0.01% 1862

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Fifth Third Bancorp's TNDM Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Tandem Diabetes Care (TNDM) stake by 2.1% in Q2 2026, selling an estimated $8.36K and leaving 22,126 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

Fifth Third Bancorp first reported a position in TNDM in Q2 2018 and has held it in 28 quarters since. The position peaked at $631K in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Fifth Third Bancorp held 22,126 shares of Tandem Diabetes Care worth $334K as of Q2 2026.
  • Fifth Third Bancorp sold 479 Tandem Diabetes Care shares in Q2 2026, an estimated $8.36K.
  • Tandem Diabetes Care made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2320 holding.
  • Fifth Third Bancorp first reported a position in Tandem Diabetes Care in Q2 2018 and has held it in 28 quarters since.
  • Fifth Third Bancorp's Tandem Diabetes Care position peaked at $631K in Q4 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.